Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Osteopore Ltd. ( (AU:OSX) ) has shared an announcement.
Osteopore Ltd. has announced the quotation of 16,949,152 new fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 11, 2025. This move is part of the company’s strategic efforts to enhance its capital structure and potentially expand its market presence, which could have significant implications for its growth and stakeholder value.
The most recent analyst rating on (AU:OSX) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Ltd. operates in the medical technology industry, focusing on the development and commercialization of bioresorbable implants that facilitate natural tissue regeneration. The company’s primary products are used in surgical procedures to aid bone healing and are targeted towards the healthcare sector.
Average Trading Volume: 837,650
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$1.79M
For detailed information about OSX stock, go to TipRanks’ Stock Analysis page.